🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase I was a single arm, open label, dose increasing study to explore the ...
Status
Unknown
Location
First Affiliated Hospital of Zhengzhou University
Start Date
2020-11-24
Trial ID
NCT04480788
Treatments Being Tested
The primary objective was to evaluate the safety of CD7 CAR-T cells for the...
Status
Not Yet Recruiting
Location
PersonGen.Anke Cellular Therapeutice Co. Ltd
Start Date
2025-03-18
Trial ID
NCT06871644
Treatments Being Tested
\*\*Translation:\*\* This clinical trial is designed as a single-arm, open...
Status
Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Start Date
2025-09-25
Trial ID
NCT07188610
Treatments Being Tested
This is a Phase I, open-label, dose-escalation clinical study with the prim...
Status
Unknown
Location
PersonGen.Anke Cellular Therapeutice Co., Ltd.
Start Date
2021-12-01
Trial ID
NCT05170568
Treatments Being Tested
Patients with acute leukemia derived from T lymphocytes have the characteri...
Status
Unknown
Location
The First Affiliared Hospital Of SOOCHOW University
Start Date
2021-03-04
Trial ID
NCT04785833
Treatments Being Tested
A Clinical Study on the Safety and Effectiveness of Targeting CD7 Chimeric ...
Status
Unknown
Location
The first affiliated hospital of medical college of zhejiang university
Start Date
2022-02-28
Trial ID
NCT05239702
Treatments Being Tested
This is a phase I, open-label, dose-escalation clinical trial. The primary ...
Status
Not Yet Recruiting
Location
PersonGen Anke Cellular Therapeutice Co,Ltd.
Start Date
2026-06-10
Trial ID
NCT07623681
Treatments Being Tested